Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

Author： Sartori Arianna Carle Dawn Freedman Mark S

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.7, 2014-05, pp. : 1019-1027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina Kappos Ludwig Sprenger Till

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis

By Wiese Michael D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1025-1035

Informa Healthcare

Access to resources Recommend Favorite

Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis

By Thööne Jan Gold Ralf

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite

From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis

Current Neuropharmacology, Vol. 15, Iss. 6, 2017-07 ,pp. : 874-891

Bentham Science Publishers

Access to resources Recommend Favorite

Fingolimod for the treatment of relapsing multiple sclerosis

By Singer Barry A

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 589-602

Informa Healthcare

Access to resources Recommend Favorite